Search

Displaying results 8551 - 8560 of 9667 in total
  1. Drug

    RPI-78M

    go.drugbank.com/drugs/DB05740
    Experimental

    RPI-78M is being developed for the treatment of multiple sclerosis (MS). Other neurological disorders that may be served by RPI-78M include myasthenia gravis (MG), muscular dystrophy (MD) and amyotrophic lateral sclerosis (ALS).

  2. Drug

    Radotinib

    go.drugbank.com/drugs/DB12323
    Investigational

    Radotinib is under investigation for the treatment of Leukemia, Myelogenous, Chronic, BCR-ABL Positive.

  3. Drug

    Pizuglanstat

    go.drugbank.com/drugs/DB19483
    Experimental

    Pizuglanstat has a monoisotopic molecular weight of 508.28 Da.

  4. Drug

    Tolboxane

    go.drugbank.com/drugs/DB19778
    Experimental

    The usage of the INN stem '-oxan(e)' in the name indicates that Tolboxane is a benzodioxane derivative. Tolboxane has a monoisotopic molecular weight of 232.16 Da.

  5. Drug

    Afacifenacin

    go.drugbank.com/drugs/DB21385
    Experimental

    Afacifenacin has a monoisotopic molecular weight of 481.2 Da.

  6. Drug

    Fosifidancitinib

    go.drugbank.com/drugs/DB21462
    Experimental

    Fosifidancitinib has a monoisotopic molecular weight of 505.12 Da.

  7. Drug

    Gemnelatinib

    go.drugbank.com/drugs/DB21513
    Experimental

    Gemnelatinib has a monoisotopic molecular weight of 524.23 Da.

  8. Drug

    Girocitinib

    go.drugbank.com/drugs/DB21692
    Experimental

    Girocitinib has a monoisotopic molecular weight of 326.14 Da.

  9. Drug

    Nedemelteon

    go.drugbank.com/drugs/DB21700
    Experimental

    Nedemelteon has a monoisotopic molecular weight of 258.14 Da.

  10. Drug

    Adekalant

    go.drugbank.com/drugs/DB20077
    Experimental

    Adekalant has a monoisotopic molecular weight of 401.23 Da.